Φορτώνει......
Intraperitoneal paclitaxel: pharmacology, clinical results and future prospects
Paclitaxel administered into the peritoneal cavity is a chemotherapy agent that shows unusually prolonged retention within the peritoneal space. Using this pharmacokinetic fact as a starting point, the use of this drug to benefit patients with peritoneal metastases was investigated. The pharmacokine...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Gastrointest Oncol |
|---|---|
| Κύριος συγγραφέας: | |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
AME Publishing Company
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8100710/ https://ncbi.nlm.nih.gov/pubmed/33968440 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-2020-03 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|